These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 35533049)
1. Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis. Tummala R; Gupta M; Devanabanda AR; Bandyopadhyay D; Aronow WS; Ray KK; Mamas M; Ghosh RK Ann Med; 2022 Dec; 54(1):1287-1296. PubMed ID: 35533049 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. Ballantyne CM; Banach M; Mancini GBJ; Lepor NE; Hanselman JC; Zhao X; Leiter LA Atherosclerosis; 2018 Oct; 277():195-203. PubMed ID: 29910030 [TBL] [Abstract][Full Text] [Related]
3. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887 [TBL] [Abstract][Full Text] [Related]
4. Bempedoic Acid: A New Tool in the Battle Against Hyperlipidemia. Powell J; Piszczatoski C Clin Ther; 2021 Feb; 43(2):410-420. PubMed ID: 33384162 [TBL] [Abstract][Full Text] [Related]
5. Role of Bempedoic Acid in Clinical Practice. Ballantyne CM; Bays H; Catapano AL; Goldberg A; Ray KK; Saseen JJ Cardiovasc Drugs Ther; 2021 Aug; 35(4):853-864. PubMed ID: 33818688 [TBL] [Abstract][Full Text] [Related]
6. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313 [TBL] [Abstract][Full Text] [Related]
7. Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance. Susekov AV; Korol LA; Watts GF Cardiovasc Drugs Ther; 2021 Aug; 35(4):841-852. PubMed ID: 33502687 [TBL] [Abstract][Full Text] [Related]
8. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial. Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM; N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796 [TBL] [Abstract][Full Text] [Related]
10. Bempedoic Acid: a cholesterol lowering agent with a novel mechanism of action. Nguyen H; Akamnonu I; Yang T Expert Rev Clin Pharmacol; 2021 May; 14(5):545-551. PubMed ID: 33691561 [TBL] [Abstract][Full Text] [Related]
11. Bempedoic acid: Review of a novel therapy in lipid management. Delevry D; Gupta EK Am J Health Syst Pharm; 2021 Jan; 78(2):95-104. PubMed ID: 33399194 [TBL] [Abstract][Full Text] [Related]
12. Bempedoic Acid: A New Drug for an Old Problem. Nguyen D; Du N; Sulaica EM; Wanat MA Ann Pharmacother; 2021 Feb; 55(2):246-251. PubMed ID: 32674598 [TBL] [Abstract][Full Text] [Related]
13. Bempedoic acid as adjunct for traditional lipid-lowering therapy in patients with hyperlipidaemia. Schimmenti C; Sucato V; Manzone E; Cancellieri G; Mortillaro F; Novo G; Galassi AR; Venturella F Coron Artery Dis; 2021 Jun; 32(4):340-344. PubMed ID: 33229935 [TBL] [Abstract][Full Text] [Related]
14. ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials. Ruscica M; Banach M; Sahebkar A; Corsini A; Sirtori CR Expert Opin Pharmacother; 2019 May; 20(7):791-803. PubMed ID: 30810432 [TBL] [Abstract][Full Text] [Related]
15. Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential. Brandts J; Ray KK Expert Opin Investig Drugs; 2020 Aug; 29(8):763-770. PubMed ID: 32564642 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. Laufs U; Banach M; Mancini GBJ; Gaudet D; Bloedon LT; Sterling LR; Kelly S; Stroes ESG J Am Heart Assoc; 2019 Apr; 8(7):e011662. PubMed ID: 30922146 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive review of statin-intolerance and the practical application of Bempedoic Acid. Yarrarapu SNS; Goyal A; Venkata VS; Panchal V; Sivasubramanian BP; Du DT; Jakulla RS; Pamulapati H; Afaq MA; Owens S; Dalia T J Cardiol; 2024 Jul; 84(1):22-29. PubMed ID: 38521120 [TBL] [Abstract][Full Text] [Related]
18. Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical Use. Drexel H; Mader A Cardiology; 2024; 149(1):71-77. PubMed ID: 37989119 [TBL] [Abstract][Full Text] [Related]
19. Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. Bilen O; Ballantyne CM Curr Atheroscler Rep; 2016 Oct; 18(10):61. PubMed ID: 27663902 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials. Laufs U; Ballantyne CM; Banach M; Bays H; Catapano AL; Duell PB; Goldberg AC; Gotto AM; Leiter LA; Ray KK; Bloedon LT; MacDougall D; Zhang Y; Mancini GBJ J Clin Lipidol; 2022; 16(3):286-297. PubMed ID: 35346603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]